2m 2m 2m 2m 2m 2m 2m
Axsome Therapeut (AXSM)
NASDAQ
$155.69-$0.38 (-0.25%)
Price as of Oct 22, 2026 7:30 PM EDT- $8.2BMarket Cap
- 22.83%1-Year Change
- BiotechnologyIndustry
Axsome Therapeut (AXSM)
$155.69-$0.38 (-0.25%)
AXSM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $156.07 | ||
Change | -$0.24 (-0.15%) | ||
Open | $156.13 | ||
High | $158.08 | ||
Low | $154.24 | ||
Previous Close | $156.31 | ||
Volume | 832,351 | ||
30-Day Average Volume | 862,393 | ||
1-Week Change | -3.54% | ||
1-Month Change | -23.16% | ||
1-Year Change | 22.83% | ||
3-Year Change | 142.91% | ||
5-Year Change | 289.20% | ||
Fundamentals | |||
Shares Outstanding | 52.4M | ||
Total Assets | $761.4M | ||
Market Cap | $8.2B | ||
Enterprise Value | $8.1B | ||
Period: QTR TTM FY | |||
Revenue | $216.4M | ||
Net Income | -$51.3M | ||
Free Cash Flow | -$33.4M | ||
EBIT | -$48.0M | ||
EBITDA | -$46.4M | ||
Net Working Capital | $196.1M | ||
EPS | -$0.99 | ||
Enterprise Value/EBITDA | -174 | ||
Enterprise Value/Revenue | 37 | ||
P/B | 98 | ||
P/E | -158 | ||
PEG | -7 | ||
Price/Free Cash Flow | -245 | ||
Price/Operating Cash Flow | -248 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue